
Entrada Therapeutics, Inc.
Entrada Therapeutics, Inc. (TRDA)
WebsitePrice
Market cap
Next catalystExpected 2H 2026VX-670 — GALILEO and separate open-label extension · Phase 1/2 dataSEC filing ↗
Cash
Chart & Events
Core Clinical
Technology Summary
Scientific context
Detailed technology interpretation
Technology advantages
Representative pipeline applications
Clinical
Upcoming clinical milestones
Other pipelines
PreINDP1P3FilingApproved